Literature DB >> 20548877

The feasibility of sentinel lymph node biopsy with a multidisciplinary cooperative team approach for the management of koreans with cutaneous malignant melanoma.

Seok-Jong Lee1, Hyun Jung Lim, Ho Youn Kim, Chang Hyun Song, Byung Soo Kim, Weon Ju Lee, Do Won Kim, Jin Hyang Jung, Ho Yong Park, Sang Gul Kim, Ghil Suk Yoon, Jae Tae Lee.   

Abstract

BACKGROUND: The regional lymph nodal status is the most powerful independent predictor of survival for patients with clinical N0 primary cutaneous malignant melanoma.
OBJECTIVE: We wanted to evaluate the feasibility and morbidity of the sentinel lymph node biopsy (SLNB) staging using a multidisciplinary team approach, in cooperation with other surgical departments, at a university hospital setting.
METHODS: Twenty two patients with cutaneous melanoma and who were treated at Kyungpook National University Hospital were included in this study. They all received SLNB, which was done by the Departments of Dermatology and General Surgery. We evaluated the feasibility and side effects of SLNB.
RESULTS: Pathologically-positive sentinel nodes were found in 7 of the 22 cases (31.8%) and all 7 patients were consequently upstaged. The whole process involved in SLNB was well tolerated by nearly all the patients, with only mild and transient complications being observed.
CONCLUSION: We suggest that in a Korean setting, utilizing SLNB with a multi-disciplinary team approach is a technically feasible procedure that is able to detect occult nodal metastasis with low morbidity rates in patients with cutaneous malignant melanoma.

Entities:  

Keywords:  Malignant melanoma; Multidisciplinary approach; Sentinel lymph node; Sentinel lymph node biopsy

Year:  2010        PMID: 20548877      PMCID: PMC2883393          DOI: 10.5021/ad.2010.22.1.26

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  20 in total

1.  Sentinel node biopsy for melanoma: Where have we been and where are we going?

Authors:  John F Thompson; Jonathan R Stretch; Roger F Uren; Vivian S Ka; Richard A Scolyer
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344

Review 2.  Recent advances in melanoma staging and therapy.

Authors:  K M McMasters; V K Sondak; M T Lotze; M I Ross
Journal:  Ann Surg Oncol       Date:  1999 Jul-Aug       Impact factor: 5.344

3.  Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial.

Authors:  C P Karakousis; C M Balch; M M Urist; M M Ross; T J Smith; A A Bartolucci
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

Review 4.  Laboratory tests and imaging studies in patients with cutaneous malignant melanoma.

Authors:  C L Huang; N Provost; A A Marghoob; A W Kopf; L Levin; R S Bart
Journal:  J Am Acad Dermatol       Date:  1998-09       Impact factor: 11.527

5.  Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.

Authors:  Anand Govindarajan; Danny M Ghazarian; David R McCready; Wey L Leong
Journal:  Ann Surg Oncol       Date:  2006-11-29       Impact factor: 5.344

Review 6.  Malignant melanoma in non-Caucasians: experience from Hawaii.

Authors:  David Scott Johnson; Shane Yamane; Shane Morita; Cyndee Yonehara; Jan H Wong
Journal:  Surg Clin North Am       Date:  2003-04       Impact factor: 2.741

Review 7.  Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma.

Authors:  Giuliano Mariani; Marco Gipponi; Luciano Moresco; Giuseppe Villa; Mirco Bartolomei; Giovanni Mazzarol; Maria Claudia Bagnara; Antonella Romanini; Ferdinando Cafiero; Giovanni Paganelli; H William Strauss
Journal:  J Nucl Med       Date:  2002-06       Impact factor: 10.057

8.  The orderly progression of melanoma nodal metastases.

Authors:  D Reintgen; C W Cruse; K Wells; C Berman; N Fenske; F Glass; K Schroer; R Heller; M Ross; G Lyman
Journal:  Ann Surg       Date:  1994-12       Impact factor: 12.969

Review 9.  Pathological and molecular assessment of sentinel lymph nodes in solid tumors.

Authors:  David N Krag; Donald L Weaver
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

10.  Sentinel node biopsy as an indicator for pelvic nodes dissection in early stage cervical cancer.

Authors:  Chae-Chun Rhim; Jong-Sup Park; Seog-Nyeon Bae; Sung-Eun Namkoong
Journal:  J Korean Med Sci       Date:  2002-08       Impact factor: 2.153

View more
  1 in total

1.  Application of sentinel lymph node biopsy in cutaneous basosquamous carcinoma.

Authors:  Irena Jankovic; Predrag Kovacevic; Milan Visnjic; Dimitrije Jankovic; Ivana Binic; Aleksandar Jankovic; Ivan Ilic
Journal:  Ann Dermatol       Date:  2011-09-30       Impact factor: 1.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.